KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Regeneron Pharmaceuticals (REGN) Exchange Rate Effect (2023 - 2025)

Regeneron Pharmaceuticals has reported Exchange Rate Effect over the past 3 years, most recently at -$300000.0 for Q4 2025.

  • Quarterly results put Exchange Rate Effect at -$300000.0 for Q4 2025, up 57.14% from a year ago — trailing twelve months through Dec 2025 was $300000.0 (up 142.86% YoY), and the annual figure for FY2025 was $300000.0, up 142.86%.
  • Exchange Rate Effect for Q4 2025 was -$300000.0 at Regeneron Pharmaceuticals, up from -$400000.0 in the prior quarter.
  • Over the last five years, Exchange Rate Effect for REGN hit a ceiling of $800000.0 in Q3 2024 and a floor of -$700000.0 in Q4 2024.
  • Median Exchange Rate Effect over the past 3 years was -$300000.0 (2024), compared with a mean of -$72727.3.
  • Peak annual rise in Exchange Rate Effect hit 500.0% in 2024, while the deepest fall reached 450.0% in 2024.
  • Regeneron Pharmaceuticals' Exchange Rate Effect stood at $200000.0 in 2023, then plummeted by 450.0% to -$700000.0 in 2024, then soared by 57.14% to -$300000.0 in 2025.
  • The last three reported values for Exchange Rate Effect were -$300000.0 (Q4 2025), -$400000.0 (Q3 2025), and $400000.0 (Q2 2025) per Business Quant data.